ESR1 and breast cancer: Patients with luminal A breast cancer were often considered to have the best prognosis, followed by patients with luminal B breast cancer.3 Expression of ER is associated with favourable prognosis and can predict the efficacy of endocrine therapies including aromatase inhibitors and tamoxifen.